| http://www.w3.org/ns/prov#value | - The addition of cystatin C, BTP and B2M to models including eGFRcr and all covariates, including urinary albumin:creatinine ratio, significantly improved risk prediction for all outcomes (p<0.001).LimitationsNo direct measurement of GFR.ConclusionsB2M, and to a lesser extent, BTP, share cystatin C???s advantage over eGFRcr in predicting outcomes, including kidney failure.
|
